Advances in Malaria Transmission-Blocking Vaccines
A special issue of Tropical Medicine and Infectious Disease (ISSN 2414-6366). This special issue belongs to the section "Vector-Borne Diseases".
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 335
Special Issue Editor
Special Issue Information
Dear Colleagues,
Globally, the past two years have not only been very challenging but have also changed the way we work and look at issues. As we forge ahead with the new ‘normal’ life in the era of COVID-19 transforming from a pandemic to an endemic disease, it is vital not to lose the considerable gain made over the years in the control of malaria through evaluation and implementation of strategic tools such as vaccines. With the ongoing implementation of the first malaria vaccine recently approved by the World Health Organization (WHO), this is an opportune time to consolidate on this landmark achievement by expanding the body of knowledge on malaria transmission-blocking vaccines that have been described by the WHO as an ideal public good. In this special edition, we have assembled an extra-ordinary compendium of top-notch researchers and global leaders to share in-depth analysis and recent advancements in the field of human malaria transmission blocking vaccines. We hope these efforts will be a catalyst to contribute towards the realization of SDG3 by 2030 in malaria endemic countries and beyond.
Dr. Muhammed Afolabi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- global public health
- malaria
- vaccines
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
